These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20214161)

  • 1. Ketosis-onset diabetes in Tunisian adults: immunological markers and beta-cell function.
    Harzallah F; Ben Brahim A; Laadhar L; Feki M; Zitouni M; Makni S; Kaabachi N; Slimane H
    East Mediterr Health J; 2010 Jan; 16(1):70-4. PubMed ID: 20214161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic instability in type 1 diabetic patients: Possible role of ketosis or ketoacidosis at onset of diabetes.
    Sassa M; Yamada Y; Hosokawa M; Fukuda K; Fujimoto S; Toyoda K; Tsukiyama K; Seino Y; Inagaki N
    Diabetes Res Clin Pract; 2008 Aug; 81(2):190-5. PubMed ID: 18514964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
    Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
    Rattarasarn C; Diosdado MA
    Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population.
    Tobon GJ; Arango A; Abad V; García J; Cuervo H; Velásquez A; Angel ID; Vega P; Abad A; Anaya JM
    Diabetes Res Clin Pract; 2006 May; 72(2):170-5. PubMed ID: 16325957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and immunological characteristics in rapid-onset type 1 diabetes with hyperamylasemia].
    Zhang C; Zhou ZG; Zhang DM; Yang XL; Zhou M; Lin J; Huang G; Wang JP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):967-71. PubMed ID: 16061004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
    Monge L; Bruno G; Pinach S; Grassi G; Maghenzani G; Dani F; Pagano G
    Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients].
    Zhang C; Zhou ZG; Lin J; Huang G; Wang JP; Zhang DM; Zhou M; Yang XL
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):797-801. PubMed ID: 18756979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X; Yang L; Zhou Z; Huang G; Yan X
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of diabetic ketoacidosis in newly diagnosed adult patients.
    Thewjitcharoen Y; Sunthornyothin S
    Diabetes Res Clin Pract; 2010 Nov; 90(2):e43-5. PubMed ID: 20843574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M; Clark A
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short duration of breast-feeding as a risk-factor for beta-cell autoantibodies in 5-year-old children from the general population.
    Holmberg H; Wahlberg J; Vaarala O; Ludvigsson J;
    Br J Nutr; 2007 Jan; 97(1):111-6. PubMed ID: 17217566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.